The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
Open accessAbstract
Identity of the Epstein-Barr virus (EBV) receptor with the complement receptor type 2 (CR2) was established in three sets of experiments using the monoclonal antibodies, HB-5 and anti-B2, which recognize a Mr 145,000 B-lymphocyte membrane protein that is CR2. First, the rank order for binding of fluoresceinated EBV to four lymphoblastoid cell lines (SB, JY, Raji, and Molt-4) was identical to the rank order for binding of HB-5 and anti-B2 by analytical flow cytometry. Second, pretreatment of cells with HB-5 followed by treatment with goat F(ab')2 fragments to mouse IgG blocked binding of fluoresceinated EBV on SB, a B-lymphoblastoid cell line. Virus attachment was not inhibited by HB-5 alone, second antibody alone, rabbit anti-C3b receptor, or UPC10 (an irrelevant monoclonal antibody). Third, transfer of CR2 from SB to protein A-bearing Staphylococcus aureus particles, to which HB-5 had been absorbed, conferred on them the specific ability to bind 125I-labeled EBV. We conclude that CR2 is the EBV receptor of human B lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,558
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
Lozzio, C., & Lozzio, B. (1975) · Blood · doi:10.1182/blood.v45.3.321.321 · Cited by 2,995
Barnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
Release of Infectious Epstein-Barr Virus by Transformed Marmoset Leukocytes
Miller, G., & Lipman, M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.1.190 · Cited by 941
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.891 · Cited by 916
Wright, S. D., Rao, P. E., Van Voorhis, W. C., Craigmyle, L. S., Iida, K., Talle, M. A., Westberg, E. F., Goldstein, G., & Silverstein, S. C. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5699 · Cited by 663
Minowada, J., ONUMA, T., & Moore, G. E. (1972) · PubMed · Cited by 646
Fearon, D. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.1.20 · Cited by 644
Self-citationAnti-Mac-1 selectively inhibits the mouse and human type three complement receptor.
Beller, D. I., Springer, T. A., & Schreiber, R. D. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.4.1000 · Cited by 606
A study of malignant tumours in Nigeria by short-term tissue culture
Pulvertaft, R. J. V. (1965) · Journal of Clinical Pathology · doi:10.1136/jcp.18.3.261 · Cited by 578
Medof, M. E., Iida, K., Mold, C., & Nussenzweig, V (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1739 · Cited by 334
Arnaout, M. A., Todd, R. F., Dana, N., Melamed, J., Schlossman, S. F., & Colten, H. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110955 · Cited by 298
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
Weis, J. J., Tedder, T. F., & Fearon, D. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.881 · Cited by 248
Self-citationIida, K., Nadler, L., & Nussenzweig, V (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.4.1021 · Cited by 243
Stages of B cell differentiation in human lymphoid tissue.
Bhan, A. K., Nadler, L. M., Stashenko, P., McCluskey, R. T., & Schlossman, S. F. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.737 · Cited by 239
Terhorst, C., Parham, P., Mann, D. L., & Strominger, J. L. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.910 · Cited by 162
Self-citationImmune Adherence by the Fourth Component of Complement
Cooper, N. R. (1969) · Science · doi:10.1126/science.165.3891.396 · Cited by 147
Genetic regulation of a structural polymorphism of human C3b receptor.
Wong, W. W., Wilson, J. G., & Fearon, D. T. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111018 · Cited by 132
Self-citationDolyniuk, M., Pritchett, R. F., & Kieff, E. D. (1976) · Journal of Virology · doi:10.1128/jvi.17.3.935-949.1976 · Cited by 128
Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies.
Daha, M. R., Bloem, A. C., & BALLIEUX, R. E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1197 · Cited by 91
Cited by
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., & Axel, R. (1986) · Cell · doi:10.1016/0092-8674(86)90590-8 · Cited by 2,002
Cohen, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430707 · Cited by 1,636
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Metadata
- Authors
- Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A., & Fearon, D. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1984-07
- Volume
- 81
- Issue
- 14
- Pages
- 4510-4514
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1967738350
- Cited by
- 939
- References
- 20
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.